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Original article
Cardiovascular system and kidney function are tightly 
linked. This cardio-renal interaction occurs primarily via 
hemodynamic factors but also via endogenous humoral fac-
tors that are associated with acute or chronic damage of the 
kidney and/or heart. Furthermore, cardiovascular and renal 
diseases share the same risk factors, including hypertension, 
glucose intolerance, obesity, etc.1,2
Noninvasive assessment of renal hemodynamics is cur-
rently possible by analyzing the intrarenal arterial waveforms 
as measured by Doppler ultrasound. The renal resistive index 
(RRI), derived from the Doppler pulsatile flow-velocity 
waveform as ((peak systolic velocity − end-diastolic veloc-
ity)/peak systolic velocity), is the most described measure in 
renal Doppler ultrasonography.3 Over the last years, RRI has 
been intensively studied to gain diagnostic and prognostic 
insights into a variety of renal clinical conditions such as 
assessment of renal allograft rejection,4,5 detection and man-
agement of renal artery stenosis in hypertensive patients,6,7 
evaluation of progression in chronic kidney disease,8 and 
prediction of renal and composite adverse outcomes in criti-
cally ill patients.9,10
Although RRI was initially considered to reflect only 
intrarenal vascular pathological processes, this index is a 
product of a complex interaction of vascular wall proper-
ties and systemic hemodynamic factors, yet most of these 
factors are insufficiently understood.3 Recently, a large com-
munity-based study reported anthropometric and hemody-
namic determinants of RRI such as age, body mass index, 
and systolic and diastolic blood pressure (BP).11 Moreover, 
in hypertensive patients, increased RRI was independently 
associated with target organ damage, such as left ventricular 
(LV) hypertrophy and carotid intima–media thickness.12–14 
Doppler Indexes of Left Ventricular Systolic and Diastolic 
Flow and Central Pulse Pressure in Relation to Renal 
Resistive Index
Tatiana Kuznetsova,1 Nicholas Cauwenberghs,1 Judita Knez,1 Lutgarde Thijs,1 Yan-Ping Liu,1 
Yu-Mei Gu,1 and Jan A. Staessen1,2
Background
The cardio-renal interaction occurs via hemodynamic and humoral fac-
tors. Noninvasive assessment of renal hemodynamics is currently pos-
sible by assessment of renal resistive index (RRI) derived from intrarenal 
Doppler arterial waveforms as ((peak systolic velocity − end-diastolic 
velocity)/peak systolic velocity). Limited information is available regard-
ing the relationship between RRI and cardiac hemodynamics. We 
investigated these associations in randomly recruited subjects from a 
general population.
METHodS
In 171 participants (48.5% women; mean age, 52.2 years), using pulsed 
wave Doppler, we measured RRI (mean, 0.60) and left ventricular outflow 
tract (LVOT) and transmitral (E and A) blood flow peak velocities and its 
velocity time integrals (VTI). Using carotid applanation tonometry, we 
measured central pulse pressure and arterial stiffness indexes such as 
augmentation pressure and carotid–femoral pulse wave velocity.
rESuLTS
In stepwise regression analysis, RRI independently and significantly 
increased with female sex, age, body weight, brachial pulse pressure, 
and use of β-blockers, whereas it decreased with body height and 
mean arterial pressure. In multivariable-adjusted models with cen-
tral pulse pressure and arterial stiffness indexes as the explanatory 
variables, we observed a significant and positive correlation of RRI 
only with central pulse pressure (P  <  0.0001). Among the Doppler 
indexes of left ventricular blood flow, RRI was significantly and posi-
tively associated with LVOT and E peak velocities (P ≤ 0.012) and VTIs 
(P ≤ 0.010).
concLuSionS
We demonstrated that in unselected subjects RRI was significantly 
associated with central pulse pressure and left ventricular systolic 
and diastolic Doppler blood flow indexes. Our findings imply that 
in addition to the anthropometric characteristics, cardiac hemody-
namic factors influence the intrarenal arterial Doppler waveform 
patterns.
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To our knowledge, no community-based study explored the 
relationship of RRI with cardiac hemodynamics. The objec-
tives of the present research were, therefore, to describe in a 
randomly recruited population sample the determinants of 
RRI and to investigate the relation of RRI with echocadio-
graphic indexes of left ventricular systolic and diastolic func-
tion, central hemodynamics, and arterial characteristics.
METHodS
Study participants
This study is nested in the Flemish Study on Environment, 
Genes and Health Outcomes (FLEMENGHO), a large fam-
ily-based population resource on the genetic epidemiology 
of cardiovascular phenotypes, for which recruitment started 
in 1985 and continued through 2010. The selection criteria 
and study design are detailed in the online Data Supplement 
Methods section. The Ethics Committee of the University 
of Leuven approved the study and participants provided 
informed consent.
The FLEMENGHO study is an on-going longitudinal pop-
ulation study and, therefore, the participants were repeatedly 
visited at home and examined at a local examination center. 
From October 2012 until June 2013, a scheduled follow-up 
examination included also renal Doppler ultrasound. From 
247 invited participants for this examination, we obtained 
informed written consent from 181 subjects (response rate 
73.3%). Because Doppler renal waveform was of insuffi-
cient quality to assess RRI, we discarded 7 subjects from the 
analysis. Furthermore, 1 participant with atrial fibrillation, 
1 renal donor, and 1 person with 2-sided polycystosis were 
excluded. Thus, the number of participants statistically ana-
lyzed totaled 171. In 4 participants, Doppler measurements 
have been done on 1 kidney because of presence of signifi-
cant renal pathology at the other kidney including kidney 
stones, renal cysts, hydronephrosis, and polycystosis.
renal doppler ultrasound
The participants refrained from smoking, heavy exercise, 
and drinking alcohol or caffeine-containing beverages for at 
least 3 hours before ultrasound examination. The BP was the 
average of 2 readings, obtained with a validated OMRON 
705IT device (Omron Corp., Tokyo, Japan) at the end of the 
ultrasound examination.
Renal gray scale and color Doppler ultrasounds were per-
formed by 1 experienced observer (T.K.), using a Vivid E9 
ultrasound scanner (GE Vingmed, Horten, Norway) interfaced 
with a 1.5- to 4.5-MHz convex transducer according to a stand-
ardized procedure.11,15 Renal imaging was performed with par-
ticipants in the supine position or, in case of insufficient image 
quality, in the left or right decubitus position. Intrarenal blood 
flow of at least 3 segmental/interlobal arteries (superior, mid-
dle, and inferior) in each kidney was recorded using Doppler 
ultrasonography. All recordings included at least 5 cardiac 
cycles and were digitally stored for off-line analysis.
Two observers independently post-processed renal 
images of each participant using the EchoPAC software ver-
sion 112. The RRIs were computed using at least 3 segmental/
interlobal arterial waveforms in each kidney as ((peak sys-
tolic velocity − end-diastolic velocity)/peak systolic veloc-
ity). The average value of the 2 observers’ measurements was 
used for statistical analysis.
To determine interobserver variability, RRIs were meas-
ured in duplicates by 2 observers in 20 subjects. The interob-
server variability was estimated using the Bland and Altman’s 
approach.16 The absolute and relative differences between 
2 observers for RRI were 0.001 ± 0.038 and −0.01 ± 6.46%, 
respectively (Supplementary Figure S1, panels A  and B). 
Interobserver correlation coefficient for RRI was 0.93 for 
both kidneys (Supplementary Figure S1, panel C).
Echocardiography
The complete echocardiographic protocol and reproduc-
ibility study are provided in the Data Supplement. Briefly, 
the same experienced physician (T.K.) did the ultrasound 
examination, using a Vivid E9 (GE Vingmed) interfaced 
with a 2.5- to 3.5-MHz phased-array probe.17 All digitally 
stored images were analyzed, averaging 3 heart cycles for sta-
tistical analysis, using a workstation running the EchoPAC, 
version 112 software package (GE Vingmed). LV mass index 
(LVMI) was LV mass divided by body surface area (BSA).
Doppler signal recorded at LV outflow tract (LVOT) from 
the apical window was used to measure peak LVOT veloc-
ity and its velocity time integral (VTI). Stroke volume was 
calculated from the pulsed wave Doppler velocity profile 
and the cross-sectional area at the LVOT. Transmitral blood 
inflow Doppler signals were used to measure peak early (E) 
and late (A) diastolic velocities, and their VTIs. From the 
pulsed wave Tissue Doppler Imaging (TDI) recordings, we 
measured peak early (e′) and late (a′) diastolic mitral annu-
lar velocities at the 4 acquisition sites (septal, lateral, inferior, 
and posterior).
Sphygmocor measurements
The complete protocol for arterial measurements is pro-
vided in the Data Supplement. Briefly, all arterial measure-
ments were obtained by an experienced observer,18 after 
the participant rested in the supine position for at least 15 
minutes. During 8 seconds, the carotid and femoral arte-
rial waveforms were recorded consequently by applanation 
tonometry, using a high-fidelity SPC-301 micromanometer 
(Millar Instruments, Inc., Houston, TX) interfaced with a 
computer running the SphygmoCor software version 8.2 
(AtCor Medical Pty. Ltd., West Ryde, New South Wales, 
Australia). To calibrate the pulse wave, brachial BP was 
recorded immediately before the tonometric recordings. We 
used the carotid pressure waveform to derive central hemo-
dynamic parameters. The software returns the central sys-
tolic BP and the pressure at the first (P1) and second (P2) 
peak or shoulder of the carotid waveform. Pulse pressure 
was defined as the difference between central systolic and 
diastolic BP. Mean arterial BP was calculated as diastolic 
BP plus one third of pulse pressure. Augmentation pressure 
was the difference between P2 and P1. Aortic pulse wave 
velocity (PWV) was measured by sequential recordings of 
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the arterial pressure wave at the carotid and femoral arter-
ies as previously described.18 Aortic PWV was calculated as 
the ratio of the pulse wave distance (in meters) to the transit 
time (in seconds).
other measurements
Detailed information on other measurements is given in 
the online Data Supplement Methods section. Venous blood 
samples were drawn after overnight fasting, in which hemo-
globin, hematocrit, blood glucose, total cholesterol, serum 
sodium, serum potassium, serum uric acid, and serum 
creatinine were determined by standard clinical laboratory 
methods. Estimated glomerular filtration rate was calculated 
using the MDRD formula.19
Statistical methods
For database management and statistical analysis, we 
used SAS software version 9.3 (SAS Institute, Cary, NC). 
Normality was evaluated by computation of skewness 
and kurtosis coefficients. The central tendency and the 
Table 1. Clinical characteristics of study participants
Characteristics Men (n = 88) Women (n = 83) P value
Anthropometrics
 Age, years 52.8 ± 14.0 52.0 ± 14.0 0.71
 Height, cm 176.2 ± 7.4 164.0 ± 6.9 <0.0001
 Weight, kg 85.1 ± 15.5 72.7 ± 14.1 <0.0001
 Body mass index, kg/m2 27.4 ± 3.7 27.0 ± 4.9 0.60
 Systolic BPa, mm Hg 128 ± 14 126 ± 17 0.29
 Diastolic BPa, mm Hg 80 ± 9 79 ± 9 0.83
 Pulse pressurea, mm Hg 49 ± 9 46 ± 11 0.15
 Mean arterial pressurea, mm Hg 96 ± 10 95 ± 11 0.52
 Heart ratea, beats/min 59 ± 9 62 ± 9 0.14
Questionnaire data
 Current smoking, n (%) 17 (19.3) 11 (13.3) 0.31
 Alcohol use, n (%) 45 (51.1) 15 (18.1) <0.0001
 Treated for hypertension, n (%) 31 (35.2) 19 (22.9) 0.09
  β-blockers, n (%) 18 (20.5) 7 (8.4) 0.03
  Diuretics, n (%) 11 (12.5) 9 (10.8) 0.74
  CCB, n (%) 9 (10.2) 3 (3.6) 0.09
  ACE or ARB, n (%) 8 (9.1) 9 (10.8) 0.70
 Cardiac diseaseb, n (%) 8 (9.1) 1 (1.2) 0.04
 Renal dysfunction, n (%) 6 (6.8) 2 (2.4) 0.17
Diabetes, n (%) 3 (3.4) 4 (4.8) 0.71
Biochemical data
 Hematocrit, % 42.7 ± 2.8 40.2 ± 2.8 <0.0001
 Blood glucose, mmol/L 4.94 ± 0.65 4.71 ± 0.47 0.008
 Total cholesterol, mmol/L 4.76 ± 0.83 5.16 ± 0.84 0.002
 Serum sodium, mmol/L 140.1 ± 2.4 140.2 ± 1.8 0.78
 Serum potassium, mmol/L 4.57 ± 0.42 4.46 ± 0.35 0.07
 Serum uric acid, µmol/L 363.8 ± 66.1 273.2 ± 71.7 <0.0001
 Serum creatinine, µmol/L 81.8 (69.0–102.5) 63.7 (53.9–77.8) <0.0001
 eGFR, ml/min per 1.73 m2 90.1 ± 18.7 93.2 ± 16.3 0.25
Values are mean ± SD or number of subjects (%) or median (10%–90% percentile). P values are for the differences between men and 
women.
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; BP, blood pressure; CCB, calcium channel block-
ers; eGFR, estimated glomerular filtration rate.
aBlood pressure and heart rate were measured after echocardiographic examination in supine position.
bCardiac disease included symptomatic heart failure (n = 2) and coronary heart disease (n = 7).
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spread of the data are reported as mean ± SD or as median 
and 10%–90% percentiles. We compared means, medi-
ans, and proportions by means of the 2-sample t-test, 
the Wilcoxon rank-sum test, and the chi-square test, 
respectively. Significance was P < 0.05 on 2-sided test. We 
searched for variables associated with RRI measured on 
a continuous scale using stepwise linear regression. The 
anthropometrics and hemodynamic variables considered 
for entry in the models were sex, age, body height, body 
weight, waist circumference, body mass index, heart rate, 
systolic and diastolic BP, pulse pressure, mean arterial 
pressure, total cholesterol, serum uric acid, serum creati-
nine, estimated glomerular filtration rate, kidney length, 
current smoking and drinking, and class of antihyper-
tensive drug treatment (diuretics, renin–angiotensin sys-
tem blockers, β-blockers, and calcium channel blockers). 
P values for independent variables to enter and to stay 
in the models were set at 0.05. We ran regression diag-
nostics to exclude possible collinearity, which affects the 
stability and inflates the standard errors of the regression 
parameters. We used multiple linear regression analysis 
to investigate the associations between RRI and explana-
tory variables, while adjusting for covariables identified 
in stepwise linear regression. We expressed multivariable-
adjusted effect sizes for a 1-SD increase in the explanatory 
variables.
Table 2. Central hemodynamics, arterial, echocardiographic, and renal characteristics of study participants
Characteristics Men (n = 88) Women (n = 83) P value
SphygmoCor measurements
 Central hemodynamicsa
  Systolic blood pressure, mm Hg 124 ± 14 126 ± 20 0.58
  Pulse pressure, mm Hg 42 ± 12 46 ± 16 0.19
  Augmentation pressure, mm Hg 12 ± 8 16 ± 10 0.004
 Pulse wave velocity, m/s 7.81 ± 1.59 7.40 ± 1.59 0.12
Echocardiographic structural indexes
 Left atrial volume index, ml/m2 26.2 ± 7.1 23.6 ± 5.9 0.01
 LV end-diastolic internal diameter, cm 5.21 ± 0.36 4.77 ± 0.37 <0.0001
 Posterior end-diastolic wall thickness, cm 1.03 ± 0.13 0.91 ± 0.11 <0.0001
 Interventricular wall thickness, cm 1.10 ± 0.18 0.96 ± 0.15 <0.0001
 LV mass index, g/m2 106.1 ± 23.0 87.5 ± 19.3 <0.0001
 LV outflow diameter, cm 2.25 ± 0.17 2.03 ± 0.15 <0.0001
Doppler volume indexes
 LVOT peak velocity, cm/s 1.10 ± 0.17 1.10 ± 0.17 0.78
 LVOT VTI , cm 22.3 ± 3.50 23.0 ± 3.81 0.23
 LVOT stroke volume, ml 88.7 ± 18.6 74.7 ± 16.9 <0.0001
 E peak, cm/s 65.0 ± 16.5 72.5 ± 16.6 0.004
 E VTI, cm 9.16 ± 2.12 9.67 ± 2.11 0.11
 A peak, cm/s 55.5 ± 13.2 64.0 ± 16.0 0.0002
 A VTI, cm 4.77 ± 1.31 5.38 ± 1.53 0.006
 E/A ratio 1.25 ± 0.50 1.23 ± 0.52 0.79
TDI indexes
 e′ peakb, cm/s 10.1 ± 3.6 10.3 ± 3.6 0.71
 a′ peakb, cm/s 9.7 ± 2.1 9.3 ± 1.9 0.24
 E/e′ ratio 6.94 ± 2.29 7.64 ± 2.36 0.05
Renal ultrasound
 Renal length, cm 11.2 ± 0.63 10.6 ± 0.77 <0.0001
 RRI 0.585 ± 0.059 0.612 ± 0.056 0.002
Values are mean ± SD. P values are for the differences between men and women.
Abbreviations: BP, blood pressure; LV, left ventricular; LVOT left ventricular outflow tract; RRI, renal resistive index; TDI, tissue Doppler imag-
ing; VTI, velocity time integral.
aMeasurements of central hemodynamics were available for 120 participants.
bAveraged of septum, lateral, inferior and posterior mitral annulus sites.
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Figure 1. The histograms of renal resistive index (RRI) of right, left, and both kidneys in the entire population. The curves represent the fitted normal 
(full line) and Kernel (dotted line) density plots.
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rESuLTS
characteristics of the participants
The 171 participants included 83 (48.5%) women and 
88 (51.5%) hypertensive participants of whom 50 (29.2%) 
were on antihypertensive drug treatment. Mean age was 
52.2 ± 14.0 years. In our study, 50 (29.2%) participants were 
on one or more antihypertensive drugs (β-blockers, 25 
patients; diuretics, 20 patients; calcium channel blockers, 
12 patients; ACE inhibitors or angiotensin receptor block-
ers, 17 patients). Table 1 lists the clinical and biochemical 
characteristics of the participants by sex. Men had higher 
body height, body weight, alcohol use, β-blockers use, 
and prevalence of cardiac disease compared to women 
(Table 1). Overall, 7 subjects (4.1%) had renal insufficiency 
(estimated glomerular filtration rate < 60 ml/min per 1.73 
m2). Hematocrit, blood glucose, serum uric acid, and serum 
creatinine were higher in men than in women (Table  1). 
Table  2 presents the hemodynamic, arterial, and echocar-
diographic characteristics of the participants by sex. In this 
cohort, women had higher central augmentation pressure 
than men (Table 2). All echocardiographic structural meas-
urements were greater in men than in women (Table  2). 
Men had higher LV outflow stroke volume than women, 
whereas women had higher transmitral Doppler diastolic 
flow velocities (E and A  velocity peaks and A  VTI) com-
pared to men (Table 2).
rri and its determinants
Figure 1 shows the distribution of RRI of left and right kid-
ney and the RRI averaged for both kidneys. The distributions 
of RRI were positively skewed (P ≤ 0.01) with the coefficients 
of skewness ranging between 0.41 and 0.54 (Figure 1). In the 
entire population, mean RRI was 0.59 ± 0.062, 0.60 ± 0.058, 
and 0.60 ± 0.059 for left, right, and for both kidneys, 
respectively. For the further statistical analyses, we aver-
aged the RRI measurements of left and right kidneys. Renal 
length was greater in men than in women, whereas women 
had higher RRI (Table 2).
Supplementary Tables S1 and S2 list the characteristics 
of participants by tertiles of the distribution of RRI. In an 
univariate analysis, the averaged RRI correlated signifi-
cantly with age, body height, systolic BP, and pulse pressure 
(Supplementary Figure S2). In stepwise regression analysis, 
RRI independently and significantly increased with age, 
female sex, body weight, and peripheral pulse pressure, 
whereas averaged RRI decreased with body height and mean 
arterial pressure (Table 3). We also noticed that, after adjust-
ment, RRI was higher in participants treated with β-blockers 
(Table 3). The covariables in the final model explained 67.6% 
of the total variance of RRI. Most of the total variance of RRI 
was explained by age (38.8%).
relation of rri with central hemodynamics and arterial 
characteristics
Table  4 presents the relationship of RRI with central 
hemodynamics and arterial characteristics, while account-
ing for age, sex, body height, body weight, and use of 
β-blockers. In an adjusted model with central systolic BP 
as the explanatory variable, we introduced diastolic BP as 
an additional covariable. In model with central pulse pres-
sure as the explanatory variable, we entered mean arterial 
pressure as an additional covariable. We observed signifi-
cant and positive correlations of RRI with central systolic 
BP (P  =  0.021) and central pulse pressure (P  <  0.0001) 
(Table  4). For a 1-SD increase in central systolic BP and 
central pulse pressure, RRI increased by 0.010 and 0.029, 
respectively. Central systolic BP and central pulse pres-
sure explained 5.0% and 14.4% of the variances in the RRI, 
respectively, that was not yet explained by other covariables. 
Table 3. Correlates of the averaged RRI in stepwise regression
Parameter
RRI
Partial R2 (%) β ± SE 95% CI P value
Age (+10 years) 38.8 0.015 ± 0.003 0.009 to 0.020 <0.0001
Being female 8.3 0.025 ± 0.007 0.011 to 0.040 <0.0001
Body height (+10 cm) 3.9 −0.021 ± 0.005 −0.031 to −0.012 <0.0001
Body weight (+10 kg) 1.6 0.011 ± 0.002 0.006 to 0.016 0.0073
Pulse pressure (+10 mm Hg) 8.7 0.035 ± 0.004 0.028 to 0.042 <0.0001
Mean arterial pressure (+10 mm Hg) 5.0 −0.022 ± 0.003 −0.029 to −0.016 <0.0001
Use of β-blockers 2.8 0.025 ± 0.008 0.009 to 0.040 0.0005
Total adjusted R2 67.6
The covariables considered for entry into the stepwise regression model were sex, age, body height, body weight, waist circumference, body 
mass index, heart rate, systolic and diastolic blood pressure, pulse pressure, mean arterial pressure, total cholesterol, serum uric acid, serum 
creatinine, eGFR, kidney length, current smoking and drinking, and class of antihypertensive drug treatment (diuretics, renin–angiotensin sys-
tem blockers, β-blockers, and calcium channel blockers). We set the P values for covariables to enter and to stay in the regression models at 
0.05. Values are mutually adjusted partial regression coefficients ± SE, 95% confidence intervals, and P values. Variance inflation factors (VIF) 
were ≤2.00 for all explanatory variables with exception of VIF for body height (VIF = 2.85).
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; RRI, renal resistive index.
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Figure 2 shows the correlations between the adjusted RRI 
and the adjusted central systolic BP and central pulse pres-
sure (P < 0.0001).
While adjusting for the important covariables including 
central pulse pressure and mean arterial pressure, we did not 
observe any significant association between RRI and arte-
rial characteristics such as augmentation pressure and aortic 
PWV (Table 4).
relation of rri with echocardiographic parameters
Table 4 lists the relationship between RRI and echocardio-
graphic indexes, while accounting for age, sex, body height, 
body weight, pulse pressure, mean arterial pressure, and 
use of β-blockers. RRI was not associated with any of the 
echocardiographic indexes reflecting LV structure (P ≥ 0.40) 
(Table  4). We observed significant and independent asso-
ciations between RRI and Doppler indexes characterizing 
blood flow during systole such as LVOT peak velocity, LVOT 
VTI, and LV stroke volume (Table 4). For a 1-SD increase 
in LVOT peak velocity, LVOT VTI, and LV stroke volume, 
RRI increased by 0.0065, 0.0088, and 0.0071, respectively. 
Furthermore, RRI was directly and significantly associated 
with transmitral Doppler diastolic indexes such as E veloc-
ity, E VTI, and E/A ratio (P ≤ 0.0027) (Table 4). For a 1-SD 
increase in E peak, E VTI, and E/A, RRI increased by 0.0097, 
Table 4. Multivariable-adjusted correlations of RRI with central blood pressure, arterial characteristics, and echocardiographic indexes
Explanatory variables
RRI
Effect size 95% CI P value
Central blood pressure and arterial characteristics
 Central systolic blood pressure (+17 mm Hg) 0.010 0.0016 to 0.019 0.021
 Central pulse pressure (+15 mm Hg) 0.029  0.020 to 0.037 <0.0001
 Augmentation pressure (+9 mm Hg) −0.0039 −0.030 to 0.017 0.59
 Pulse wave velocity (+1.6 m/s) 0.0069 −0.0017 to 0.015 0.12
Echocardiographic structural indexes
 Left atrial volume index (+6.7 ml/m2) 0.0048 −0.0018 to 0.012 0.15
 LV end-diastolic internal diameter (+0.43 cm) −0.0022 −0.0091 to 0.0047 0.53
 Posterior end-diastolic wall thickness (+0.14 cm) −0.0043  −0.012 to 0.0033 0.87
 Interventricular wall thickness (+0.18 cm) 0.0006 −0.0065 to 0.0077 0.43
 LV mass index (+23 ml/m2) −0.0028 −0.0093 to 0.0037 0.40
Doppler indexes
 LV outflow
  LVOT peak velocity (+17 cm/s) 0.0065 0.0015 to 0.011 0.012
  LVOT VTI (+3.7 cm) 0.0088 0.0037 to 0.014 0.0008
  LVOT stroke volume (+19 ml) 0.0071 0.0010 to 0.013 0.023
 Transmitral diastolic inflow
  E peak velocity (+17 cm/s) 0.0097 0.0034 to 0.016 0.0027
  E VTI (+2.1 cm) 0.0077 0.0017 to 0.013 0.010
  A peak velocity (+15 cm/s) −0.0021 −0.0093 to 0.0051 0.58
  A VTI (+1.5 cm) −0.0007 −0.0081 to 0.0067 0.85
  E/A ratio (+0.51) 0.013 0.0046 to 0.020 0.0017
 TDI indexes
  e′ peak velocity (+3.6 cm/s) 0.0086 −0.0014 to 0.018 0.10
  a′ peak velocity (+2.0 cm/s) −0.0044 −0.010 to 0.0016 0.15
 E/e′ ratio (+2.4) 0.0053 −0.0017 to 0.012 0.14
Effect sizes and corresponding 95% CI are expressed for a 1-SD increase in the explanatory variables and were adjusted for age, sex, body 
height, body weight, and use of β-blockers. For central systolic blood pressure, adjusted model included diastolic blood pressure. For central 
pulse pressure, adjusted model included mean arterial pressure. For augmentation pressure and pulse wave velocity, adjusted models included 
both mean arterial pressure and central pulse pressure. For echocardiographic indexes, adjusted model included mean arterial pressure and 
brachial pulse pressure.
Abbreviations: CI, confidence interval; LV, left ventricular; LVOT, left ventricular outflow tract; RRI, renal resistive index; TDI, tissue Doppler 
imaging; VTI, velocity time integral.
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0.0077, and 0.013, respectively (Table  4). We repeated our 
analyses after exclusion of subjects on antihypertensive 
drugs. In 121 untreated subjects, our findings remained con-
sistent (Supplementary Table S3).
The adjusted RRI significantly correlated with the adjusted 
LVOT peak velocity (r  =  0.19) and LVOT VTI (r  =  0.23) 
(Figure 3). Moreover, significant correlations were observed 
between the adjusted RRI and diastolic Doppler indexes 
with Pearson coefficients ranging between 0.17 and 0.22 
(Figure 3).
diScuSSion
The key finding of this study was that RRI was signifi-
cantly and independently associated with central pulse pres-
sure and intracardiac Doppler blood flow indexes. In our 
population study, for the first time, we described the relation 
between renal and cardiac Doppler blood flow waveforms. 
Furthermore, in our study, we reported other anthropomet-
ric and hemodynamic determinants of RRI that are in line 
with previous reports in the general population,11 hyperten-
sive patients,14 and renal allograft recipients.5 In particular, 
we found that in our cohort, RRI significantly and inde-
pendently increased with female sex, age, peripheral pulse 
pressure, and body weight and decreased with body height 
and mean arterial pressure. Moreover, RRI significantly and 
independently increased with use of β-blockers.
Previous studies showed that the Doppler arterial wave-
form signal obtained in the intrarenal arteries is the prod-
uct of a complex interaction between a number of factors 
such as systemic hemodynamics and peripheral vascular 
resistance and compliance.3 Indeed, experimental studies 
demonstrated that impaired renal vascular compliance and 
increased pulse pressure lead to significant changes in RRI of 
isolated perfused rabbit kidneys.20,21
Peripheral arterial resistance is a main determinant of 
mean arterial pressure and depends on the physical charac-
teristics of the arterial tree. On the other hand, the pulsatile 
component, represented by pulse pressure, depends on com-
pliance of aorta and large arteries. The aortic walls elastically 
expand to accommodate the ejected blood during systole 
and, therefore, dampen pulsatility and maintains a continu-
ous blood flow from the heart to the periphery. With aging, 
the rigidity is more pronounced in the aorta than in periph-
eral conduit arteries, leading to less protection of the micro-
circulation from high-pressure transmission in organs with 
high resting flow, such as the kidneys.22 In fact, increased 
pulsatile stress leads to tearing of endothelial and smooth 
muscle cells of small arteries in kidney.23 Along these lines, 
several studies have shown that pulse pressure is an inde-
pendent prognostic factor for cardiovascular mortality and 
morbidity in patients with chronic kidney disease24 and in 
renal transplant patients.25
To our knowledge, only 2 previous reports in hyperten-
sive patients26,27 addressed the associations of RRI with 
central pulse pressure and arterial stiffness. In keeping with 
our observations, these studies26,27 demonstrated significant 
association between RRI and aortic pulse pressure inde-
pendent of other covariables. Similar to our findings, no 
significant associations were observed with arterial stiffness 
indexes such as augmentation pressure and carotid–femoral 
pulse wave velocity after adjustment for important covari-
ables including age.26,27
In addition to vascular properties and central pulse pres-
sure, another important factor influencing the Doppler-
based RRI is renal blood flow.28 The kidney is one of the 
peripheral territories with the highest perfusion because 
of its pivotal role in the metabolic balance. In fact, kidneys 
receive approximately 15%–25% of total cardiac output via 
renal arteries depending on the state of body and the volume 
of blood that the LV ejects. Using Doppler echocardiogra-
phy, we could also quantify intracardiac blood flows through 
quantification of blood velocities during systole and dias-
tole.29 Previous studies showed that changes in the total cir-
culating volume (preload) significantly influenced Doppler 
blood flow velocity profiles.30,31
So far, only 1 study32 in 99 patients with treated essen-
tial hypertension investigated the relationship between 
RRI and the velocity ratio of atrial filling to early diastolic 
LV filling (A/E ratio). However, in this study, the authors 
Figure 2. Scatter plots of renal resistive index (RRI) vs. central systolic blood pressure (SBP; panel a) and central pulse pressure (PP; panel B) in multivar-
iable-adjusted analyses. The full and dotted lines represent the regression line and the 95% confidence interval, respectively. The regression slopes were 
standardized to the distribution in all 120 subjects with available central hemodynamics (mean and ratio) of age, sex, and anthropometric characteristics.
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did not observe an independent association between RRI 
and LV transmitral A/E ratio.32 Moreover, the authors did 
not investigate associations between RRI and peak early LV 
diastolic flow velocity or LV peak systolic velocity and their 
VTIs.32 Thus, to our knowledge, our study was the first to 
assess in a general population the correlation between RRI 
and Doppler indexes of LV peak systolic and diastolic blood 
flow velocities. With adjustments applied, we demonstrated 
in continuous analyses that RRI significantly increased with 
systolic and early diastolic intracardiac Doppler blood flow. 
Our findings imply that exposure of small renal arteries to 
high blood flow in addition to high pulsatile pressure leads 
to increased RRI and might in long run result to microvas-
cular damage and, therefore, renal insufficiency.23 Along 
these lines, recent study in hypertensive patients33 demon-
strated that impairment of renal hemodynamics as assessed 
by increased RRI was associated with an increased risk of 
cardiovascular and renal outcomes.
The present study must be interpreted within the context 
of its potential limitations. First, echocardiographic measure-
ments are prone to measurements errors due to bad visualiza-
tion, signal noise, and acoustic artifacts. In the present study, 
Figure 3. Scatter plots of renal resistive index (RRI) vs. left ventricular outflow tract (LVOT) systolic (panel a) and transmitral diastolic (panel B) Doppler 
flow indexes in multivariable-adjusted analyses. The full and dotted lines represent the regression line and the 95% confidence interval, respectively. The 
regression slopes were standardized to the distribution in all 171 subjects (mean and ratio) of age, sex, and anthropometric and hemodynamic charac-
teristics. Abbreviations: SV, stroke volume; VTI, velocity time integral.
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only 1 experienced observer recorded all cardiac and renal 
ultrasound images for off-line analyses. Furthermore, digitally 
stored renal images were centrally post-processed using dedi-
cated software by 2 observers in duplicate. Second, our sample 
size was smaller than in published studies in general popu-
lation11 or in hypertensive patients.12–14 We, therefore, could 
not rule out that the associations of RRI with some indexes 
reflecting arterial stiffness and LV structure that failed to reach 
statistical significance were due to a type II error. However, the 
research question addressed in this study and our conclusions 
were expanding the findings of previous publications.11–14 
Third, the cross-sectional design of the study does not allow 
for a causal interpretation of the relationships found.
In conclusion, we demonstrated that in unselected subjects, 
RRI was significantly associated with central pulse pressure 
and LV systolic and diastolic Doppler blood flow indexes. 
Our findings imply that the interaction between the heart 
and peripheral circulation in the kidney is a complex physi-
ological phenomenon. In addition to renal vascular proper-
ties, the anthropometric and cardiac hemodynamic factors 
influenced the intrarenal arterial Doppler waveform patterns. 
Further longitudinal population studies are required to clar-
ify whether early detection of Doppler changes in intrarenal 
arteries might yield an improvement in the adverse cardio-
vascular and renal outcome in general population.
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Supplemental Methods  
Study Design  
This study is nested in the Flemish Study on Environment, Genes and Health Outcomes 
(FLEMENGHO), a large family-based population resource on the genetic epidemiology of 
cardiovascular phenotypes, for which recruitment started in 1985 and continued through 
2010. The FLEMENGHO study consists of a random population sample stratified by sex and 
age from a geographically defined area in northern Belgium. The initial participation rate was 
78.0% (1). Seven Belgian municipalities provided listings of all inhabitants sorted by address. 
Households, subjects living at the same address, were the sampling unit. They were 
numbered consecutively and a random number list was generated by a SAS randomisation 
function (SAS Institute, Car, NC). Households with a list matching number were invited. The 
Ethics Committee of the University of Leuven approved the study and participants provided 
informed consent. 
Echocardiography   
The participants refrained from smoking, heavy exercise, and drinking alcohol or caffeine-
containing beverages for at least 3 hours before echocardiography.  The blood pressure 
during echocardiography was the average of two readings, obtained with a validated 
OMRON 705IT device (Omron Corp., Tokyo, Japan) at the end of the echocardiographic 
examination.  
Data Acquisition  
One experienced physician (T.K.) did the ultrasound examination, using a Vivid E9 (GE 
Vingmed, Horten, Norway) interfaced with a 2.5- to 3.5-MHz phased-array probe, according 
to the recommendations of the American Society of Echocardiography (2). With the subjects 
in partial left decubitus and breathing normally, the observer obtained images, together with 
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a simultaneous ECG signal, along the parasternal long and short axes and from the apical 4- 
and 2 chamber long-axis views.  All recordings included at least 5 cardiac cycles and were 
digitally stored for off-line analysis.  M-mode echocardiograms of the LV were recorded from 
the parasternal long-axis view under control of the two-dimensional image.  The ultrasound 
beam was positioned just below the mitral valve at the level of the posterior chordae 
tendineae. To record pulsed-wave Doppler LV outflow and mitral inflow velocities from the 
apical window, the observer positioned the Doppler sample volume in the LV outflow tract 
(LVOT) and at the mitral valve tips, respectively.  
 Using TDI (Tissue Doppler Imaging), the observer recorded low-velocity, high-
intensity myocardial signals at a high frame rate (>190 FPS), while adjusting the imaging 
angle to ensure a parallel alignment of the ultrasound beam with the myocardial segment of 
interest.  From the apical window, the sonographer placed a 5-mm Doppler sample at the 
septal, lateral, inferior and posterior sites of the mitral annulus.   
Off-Line Analysis  
One experienced physician (T.K.) analyzed digitally stored images, averaging 3 heart cycles 
for statistical analysis, using a workstation running the EchoPac, version 112 software 
package (GE Vingmed, Horten, Norway).  The LV internal diameter and interventricular 
septal and posterior wall thickness were measured at end-diastole from the 2 dimensionally 
guided M-mode tracing according to guidelines (2). When optimal orientation of M-mode 
ultrasound beam could not be obtained, the reader performed linear measurements on 
correctly oriented two-dimensional images.  End-diastolic LV dimensions were used to 
calculate LV mass by an anatomically validated formula (3). LV mass index (LVMI) was LV 
mass divided by body surface area (BSA), calculated as body weight0.425 (in kg) x body 
height0.725 (in cm) x 0.007184. We measured left atrial (LA) dimensions in 3 orthogonal 
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planes: the parasternal long, lateral, and supero-inferior axes.  LA volume was calculated 
using the prolate-elipsoid method and was indexed to BSA (4).  
 Doppler signal recorded at the LVOT was used to measure peak LVOT velocity and 
its velocity time integral (VTI). Stroke volume was calculated from the pulsed-wave Doppler 
velocity profile and the cross sectional area at the LVOT. From the transmitral flow signal, we 
measured peak early diastolic velocity (E), peak late diastolic velocity (A), and their VTIs.  
From the TDI recordings, we measured peak early (e') and late (a') diastolic mitral annular 
velocities at the 4 acquisition sites (septal, lateral, inferior, and posterior). 
Reproducibility  
To determine intra-observer reproducibility, the experienced echocardiographists (T.K.) 
analyzed the echocardiograms of 17 subjects twice.  Intra-observer reproducibility coefficient 
of a measurement was the 2SD interval about the mean of the relative differences across 
pairwise readings. The intra-observer reproducibility was 2.2% for LV internal end-diastolic 
diameter, 4.6% for LV wall thickness, 4.3% for LV mass. For conventional Doppler 
parameters, the reproducibility was 5.0% for transmitral E peak, 6.6% for transmitral A peak, 
6.3% for LVOT peak velocity and 6.4% for LVOT VTI.  For tissue Doppler velocities, as 
reported previously, the reproducibility across the four sampling sites ranged from 4.5% to 
5.3% for e’ velocities and from 4.0% to 4.5% for a’ velocities. 
SphygmoCor Measurements 
All arterial measurements were obtained by an experienced observer according standardized 
protocol (5), after the participant rested in the supine position for at least 15 min. During 8 
seconds, the carotid and femoral arterial waveforms were recorded consequently by 
applanation tonometry, using a high-fidelity SPC-301 micromanometer (Millar Instruments, 
Inc., Houston, TX, USA) interfaced with a computer running the SphygmoCor software 
version 8.2 (AtCor Medical Pty. Ltd., West Ryde, New South Wales, Australia). Recordings 
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were discarded if systolic or diastolic variability of consecutive waveforms exceeded 5% or if 
pulse wave amplitude was less than 80 mV. To calibrate the pulse wave, brachial blood 
pressure blood pressure was recorded immediately before the tonometric recordings. 
Systolic and diastolic brachial blood pressure was the average of three consecutive obtained 
readings, using a validated OMRON 705CP oscillometric sphygmomanometer (Omron Inc., 
Kyoto, Japan). A standard cuff of 22x12 cm with an inflatable bladder was used for subjects 
with an arm circumference of less than 32 cm. For greater arm circumferences, a cuff with a 
35x15 cm bladder was used.  
 We used the carotid pressure waveform to derive central hemodynamic parameters. 
The software returns the central systolic blood pressure and the pressure at the first (P1) and 
second (P2) peak or shoulder of the carotid waveform. Pulse pressure was defined as the 
difference between central systolic and diastolic blood pressure. Mean arterial blood 
pressure was calculated as diastolic blood pressure plus one third of pulse pressure. 
Augmentation pressure was the difference between P2 and P1, and the augmentation index 
(cAI) was the ratio of augmentation pressure to central pulse pressure, expressed as a 
percentage. Aortic pulse wave velocity (PWV) was measured by sequential recordings of the 
arterial pressure wave at the carotid and femoral arteries as previously described (5). 
Distances were determined from the carotid sampling site to the suprasternal notch (distance 
A) and from the suprasternal notch to the femoral artery (distance B). PWV distance was 
calculated as distance B minus distance A. Pulse transit time was defined as the time interval 
between initial increase in carotid and femoral waveforms and was averaged over 10 
consecutive beats. Aortic PWV was calculated as the ratio of the pulse wave distance (in 
meters) to the transit time (in seconds). 
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Other Measurements 
At the examination centre, trained study nurses administered a questionnaire to collect 
detailed information on each subject’s medical history, smoking and drinking habits, and 
intake of medications.  Hypertension was a blood pressure of at least 140 mm Hg systolic or 
90 mm Hg diastolic (average of 5 consecutive auscultatory readings at the examination 
centre) or the use of antihypertensive drugs.  Body mass index was weight in kilograms 
divided by the square of height in meters. Obesity was a body mass index of 30 kg/m² or 
higher.  
Blood venous samples were drawn after overnight fasting, in which haematocrit, 
blood glucose, total cholesterol, serum sodium, serum potassium, serum uric acid (SUA) and 
serum creatinine were determined by standard clinical laboratory methods. Estimated 
glomerular filtration rate (eGFR) was calculated using the CKD-EPI (Chronic Kidney Disease 
Epidemiology Collaboration) formula (6). Renal failure was defined as an eGFR <60 ml/min 
per 1.73m² body surface in combination with a serum creatinine level >133 µmol/L for men 
and >124 µmol/L for women. Diabetes was defined as a fasting blood glucose level of more 
than 7.0 mmol/L or use of antidiabetic agents.  
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Supplemental Table S1. Clinical characteristics of study participants by tertiles of the 
distribution of RRI 
 Categories of RRI  
Characteristics n=56  n=56  n=59 P value 
RRI  0.537 ± 0.024 0.590 ± 0.011 0.663 ± 0.040  
    Age, y  43.8 ± 11.0 49.3 ± 13.1 63.7 ± 9.1 <0.0001 
    Height, cm   174.8 ± 8.5 170.6 ± 9.2 165.7 ± 8.4 <0.0001 
    Weight, kg   82.2 ± 14.8 77.9 ± 13.6 77.2 ± 15.6 0.15 
    Body mass index, kg/m²  26.8 ± 4.1 26.7 ± 4.0 28.0 ± 4.7 0.20 
    Systolic BP*, mmHg   122 ± 11 122 ± 16 136 ± 15 <0.0001 
    Diastolic BP*, mmHg  79 ± 9 78 ± 10 81 ± 8 0.32 
    Pulse pressure*, mmHg 43 ± 6 44 ± 9 55 ± 10 <0.0001 
    Mean arterial pressure*, mmHg 94 ± 9 93 ± 12 99 ± 10 0.002 
    Heart rate*, beats/min  61.3 ± 9.2 60.4 ± 9.0 59.5 ± 8.5 0.57 
Questionnaire data     
    Current smoking, n (%)   10 (17.9) 10 (17.9) 8 (13.6) 0.78 
    Alcohol use, n (%)   25 (44.6) 19 (33.9) 16 (27.1) 0.14 
    Treated for hypertension, n (%)   8 (14.3) 12 (21.4) 30 (50.8) <0.0001 
β-blockers, n (%) 2 (3.6) 5 (8.9) 18 (30.5) <0.0001 
Diuretics, n (%)   3 (5.4) 2 (3.6) 15 (25.4) 0.0003 
CCB, n (%)   1 (1.8) 3 (5.4) 8 (13.6) 0.05 
ACE or ARB, n (%)   4 (7.1) 3 (5.4) 10 (17.0) 0.08 
    Cardiac disease**, n (%)   3 (5.4) 0 6 (10.2) 0.05 
    Renal dysfunction, n (%) 0  1 (1.8) 7 (11.9) 0.02 
    Diabetes, n (%) 0  1 (1.8) 6 (10.2) 0.02 
Biochemical data     
    Hematocrit, % 42.5 ± 3.3 40.6 ± 2.8 41.3 ± 2.7 0.004 
    Blood glucose, mmol/L 4.69 ± 0.44 4.71 ± 0.53 5.07 ± 0.66 0.0002 
    Total cholesterol, mmol/L 4.78 ± 0.71 5.20 ± 0.98 4.88 ± 0.82 0.02 
    Serum sodium, mmol/L 140.0 ± 1.4 140.1 ± 1.8 140.3 ± 2.9 0.83 
    Serum potassium, mmol/L 4.43 ± 0.38 4.62 ± 0.37 4.50 ± 0.39 0.03 
    Serum uric acid, µmol/L 320 ± 76 313 ± 85 325 ± 86 0.74 
    Serum creatinine, µmol/L 79.1 (60.1-92.8) 70.7 (53.0-90.2) 69.8 (57.4-99.9) 0.24 
    eGFR, ml/min per 1.73m² 97.6 ±12.4 96.5 ± 16.7 81.2 ± 18.1 <0.0001 
Values are mean±SD or number of subjects (%) or median (10%-90% percentile). P values are for the differences in prevalence 
rates or means across tertiles of the RRI distribution. *Blood pressure and heart rate were measured after echocardiographic 
examination in supine position. ** Cardiac disease included heart failure (n=2) and ischemic heart disease (n=7). BP, blood 
ressure; CCB, calcium channel blockers; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; eGFR, 
estimated glomerular filtration rate.
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Supplemental Table S2. Central hemodynamics, arterial and echocardiographic 
characteristics and renal length of study participants by tertiles of the distribution of RRI 
 Categories of RRI  
Characteristics n=56 n=56 n=59 P value 
RRI 0.537 ± 0.024 0.590 ± 0.011 0.663 ± 0.040  
Sphygmocor measurements     
Central hemodynamics*     
    Systolic blood pressure, mmHg 120 ± 11 121 ± 15 138 ± 22 <0.0001 
    Pulse pressure, mmHg 39 ± 10 41 ± 10 57 ± 18 <0.0001 
    Augmentation pressure, mmHg 10 ± 6 12 ± 8 23 ± 10 <0.0001 
Pulse wave velocity, m/s 7.18 ± 1.45 7.30 ± 1.52 8.37 ± 1.57 0.0002 
Echocardiographic structural indexes     
    Left atrial volume index, ml/m² 22.4 ± 5.2 23.5 ± 4.9 28.7 ± 7.7 <0.0001 
    LV end-diastolic internal diameter, cm 5.06 ± 0.38 4.98 ± 0.44 4.95 ± 0.45 0.35 
    Posterior end-diastolic wall thickness, cm 0.97 ± 0.13 0.93 ± 0.12 1.00 ± 0.14 0.02 
    Interventricular wall thickness, cm 1.02 ± 0.16 0.98 ± 0.14 1.10 ± 0.20 0.001 
    LV mass index, g/m² 94.2 ± 20.6 91.5 ± 21.5 105.1 ± 25.1 0.003 
    LV outflow diameter, cm 2.20 ± 0.18 2.12 ± 0.19 2.12 ± 0.20 0.04 
Doppler volume indexes     
    LVOT peak velocity, cm/s 1.07 ± 0.15 1.12 ± 0.16 1.11 ± 0.19 0.30 
    LVOT VTI , cm 21.4 ± 3.20 22.7 ± 3.10 23.7 ± 4.22 0.003 
    LVOT stroke volume, ml 81.2 ± 16.5 81.2 ± 19.7 83.0 ± 21.1 0.84 
    E peak, cm/s      70.0 ± 15.5 70.7 ± 17.9 65.3 ± 17.0 0.17 
    E VTI, cm 9.45 ± 1.99 9.66 ± 2.09 9.12 ± 2.27 0.38 
    A peak, cm/s   53.3 ± 12.4 56.8 ± 14.5 68.2 ± 14.1 <0.0001 
    A VTI, cm 4.47 ± 1.19 4.79 ± 1.45 5.89 ± 1.32 <0.0001 
    E/A ratio 1.40 ± 0.52 1.35 ± 0.57 0.99 ± 0.30 <0.0001 
TDI indexes     
    e’ peak**, cm/s 11.7 ± 3.5 11.1 ± 3.6 7.9 ± 2.3 <0.0001 
    a’ peak**, cm/s 9.2 ± 1.9 9.4 ± 2.1 9.8 ± 2.0 0.37 
    E/e’ ratio 6.28 ± 1.47 6.68 ± 1.73 8.81 ± 2.74 <0.0001 
Renal ultrasound     
    Renal length, cm 11.02 ± 0.64 11.01 ± 0.66 10.73 ± 0.88 0.06 
Values are mean±SD. P values are for the differences in means across tertiles of the RRI distribution. *Measurements of central 
haemodynamics were available for 120 participants. **Averaged of septum, lateral, inferior and posterior mitral annulus sites. 
BP, blood pressure; LV, left ventricular; LVOT left ventricular outflow tract; VTI, velocity time integral; TDI, tissue Doppler 
imaging. 
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Supplemental Table S3. Multivariable-adjusted correlations of RRI with central blood 
pressure, arterial characteristics and echocardiographic indexes in untreated participants 
Central blood pressure and arterial 
characteristics 
   
    Central systolic blood pressure (+17 mmHg) 0.019 0.0097 to 0.029 <0.0001 
    Central pulse pressure (+15 mmHg) 0.026 0.015 to 0.035 <0.0001 
    Augmentation pressure (+9 mmHg) -0.0050 -0.019 to 0.009 0.49 
    Pulse wave velocity (+1.6 m/s) 0.0051 -0.0056 to 0.016 0.35 
Effect sizes and corresponding 95%CI are expressed for a 1-SD increase in the explanatory variables and were adjusted for 
age, sex, body height, body weight and use of β blockers. For central systolic blood pressure, adjusted model included diastolic 
blood pressure. For central pulse pressure, adjusted model included mean arterial pressure. For augmentation pressure and 
pulse wave velocity, adjusted models included both mean arterial pressure and central pulse pressure. For echocardiographic 
indexes, adjusted model included mean arterial pressure and brachial pulse pressure. RRI indicates renal resistive index; CI, 
confidence interval; LV, left ventricular; LVOT, left ventricular outflow tract; VTI, velocity time integral; TDI, tissue Doppler 
imaging.  
 RRI 
Explanatory variables Effect size 95% CI P value 
Echocardiographic structural indexes   
    Left atrial volume index (+6.7 ml/m²) 0.0046 -0.0047 to 0.014 0.33 
    LV end-diastolic internal diameter (+0.43 cm) -0.0056 -0.014 to 0.0025 0.17 
    Posterior end-diastolic wall thickness (+0.14 cm) -0.0085 -0.018 to 0.00076 0.071 
    Interventricular wall thickness (+0.18 cm) -0.0031 -0.013 to 0.0067 0.53 
    LV mass index (+23 ml/m²) -0.0084 -0.018 to 0.0011 0.084 
Doppler indexes  
LV outflow     
    LVOT peak velocity (+17 cm/s) 0.0054 -0.00041 to 0.011 0.068 
    LVOT VTI (+3.7 cm) 0.0092 0.0030 to 0.015 0.0038 
    LVOT stroke volume (+19 ml) 0.0053 -0.0027 to 0.013 0.18 
Transmitral diastolic inflow    
    E peak velocity (+17 cm/s) 0.0097 0.0027 to 0.017 0.0072 
    E VTI (+2.1 cm) 0.0079 0.0011 to 0.014 0.023 
    A peak velocity (+15 cm/s) -0.0072 -0.016 to 0.0024 0.14 
    A VTI (+1.5 cm) -0.011 -0.022 to 0.00026 0.056 
    E/A ratio (+0.51) 0.013 0.0048 to 0.021 0.0022 
TDI indexes    
    e’ peak velocity (+3.6 cm/s) 0.0076 -0.0036 to 0.019 0.18 
    a’ peak velocity (+2.0 cm/s) -0.0080 -0.015 to -0.00092 0.027 
    E/e’ ratio (+2.4) 0.0086 -0.0019 to 0.019 0.11 
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Supplemental Figures  
Supplemental Figure S1.  Panels A and B show Bland-Altman plots with absolute and 
relative differences of pairwise RRI readings, respectively. Biases and 95% limits of 
agreement are represented by full and dotted lines, respectively. Panel C shows the 
correlation between pairwise readings of RRI done by the 2 observers. Black and red lines 
represent line of identity and correlation line, respectively.  
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Supplemental Figure S2. Univariate relation of RRI with age, body height, body 
weight, systolic and diastolic blood pressure and peripheral pulse pressure. Each 
panel shows the regression line, the Pearson correlation coefficient r and the 
corresponding P value. BP, blood pressur . 
